Sign in
Taking people in United StatesPhase 1/2

Spinal cord stimulation for long-standing neck-level spinal cord injury

Tests an epidural stimulation device in adults with chronic cervical spinal cord injury.

Key facts

Who runs it
University of Minnesota
Where
Minneapolis, United StatesSee the site
Trial code
Registry title
CE-STAND: Cervical Epidural STimulation After Neurologic Damage
Status
Recruiting
Phase
Phase 1/2
People taking part
36 people, planned
Started
15 Mar 2026
Expected to end
30 Jul 2030
Type of study
Interventional
Treatments tested
  • Epidural Spinal Cord Stimulation System
Record updated
27 March 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with a long-standing, stable spinal cord injury in the neck. They must also have problems with automatic body functions, such as blood pressure control. The trial tests a spinal cord stimulation device placed in surgery.

Age
22 years or older
Sex
All sexes
Disease stage
Stable, motor-complete spinal cord injury between C4 and C7, ASIA A or B. More than 1 year since the injury, and at least 6 months since any spinal hardware surgery. Reflexes below the injury must still work.
Earlier treatment
People cannot join if they had radiation exposure, such as fluoroscopy, in another study in the last 12 months. Botulinum toxin, an intrathecal baclofen pump or antispasmodics are not allowed unless the study lead approves.
Biomarker or test result
A tilt table test must show heart and blood pressure control problems. No voluntary leg movement on EMG (muscle activity) testing of both legs.

Main reasons for not taking part

  • Needs breathing support, such as a ventilator or diaphragm pacer
  • Repeated autonomic dysreflexia (sudden dangerous blood pressure rises), or stroke or heart attack linked to it
  • Heart or lung disease that makes surgery more dangerous, or cannot stop blood thinners around surgery
  • Unhealed spinal fracture, pressure ulcers or severe joint stiffness
  • Current pregnancy, significant depression, drug abuse or need for opioid pain medicines

The registry criteria, word for word

Show all 27 criteriaShow less

Who can take part

  • Twenty two years of age or older
  • Able to undergo the informed consent/assent process
  • Stable, motor-complete SCI
  • Discrete SCI between C4 and C7 (upper extremity weakness)
  • ASIA A or B SCI Classification
  • Medically stable in the judgment of the PI
  • Intact segmental reflexes below the lesion of injury
  • Greater than 1 year since initial injury and at least 6 months from any required spinal instrumentation
  • Normal or corrected-to-normal vision to accurately perceive visual stimuli on the N-back task screen, and sufficient hearing ability to accurately perceive auditory stimuli during the task
  • Willing to attend all scheduled appointments

Who cannot take part

  • Patients who have participated in another study within the last 12 months in which they have received fluoroscopic or other related radiation exposure
  • Current and anticipated need for opioid pain medications or pain that would prevent full participation in the program in the judgment of the PI
  • Treatment with botulinum toxin, intrathecal baclofen pump, and antispasmodics will not be permitted unless discussed with and approved by the study PI
  • Diseases and conditions that would increase the morbidity and mortality of this surgery such as cardiopulmonary
  • Individuals who have history of recurrent autonomic dysreflexia in the judgment of the PI
  • Significant dysautonomia that would prohibit rehabilitation or any history of cerebrovascular accident or myocardial infarction associated with autonomic dysreflexia. A single tilt table test with syncope, presyncope, or SBP < 50 or > 200
  • Failure to exhibit cardiovascular autonomic dysfunction on tilt table testing
  • Other conditions that would make the subject unable to participate in testing/rehabilitation in the judgment of the PI
  • Clinically significant mental illness in the judgment of the PI
  • Patients with a history of significant depression or drug abuse
  • Individuals who require respiratory support, including ongoing or intermittent use of a ventilator and/or diaphragmatic pacer
  • Inability to withhold antiplatelet/anticoagulation agents perioperatively
  • Volitional movements present during EMG testing in bilateral lower extremities
  • Unhealed spinal fracture
  • Presence of significant contracture with loss of greater than two-thirds range of motion
  • Presence of pressure ulcers
  • Current Pregnancy

Where in United States

  • University of MinnesotaMinneapolis, United StatesContact: Ann Parr, MD, PhDTaking people

About the trial

What the trial wants to find out

CE-STAND aims to address three areas under-represented in research: chronic, cervical, and autonomic dysfunction. It is both significant and highly impactful, as treating autonomic dysfunction could substantially improve function and quality of life (QoL) in chronic cervical SCI patients.

The group in the trial

  • Spinal injury patientsTreatment being tested

    Experimental: Individuals with cervical SCI comparing stimulation "on" vs "off" longitudinally.

    Treatment: Epidural Spinal Cord Stimulation System

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
CE-STAND: Cervical Epidural STimulation After Neurologic Damage
Plain-language title
Spinal cord stimulation for long-standing neck-level spinal cord injuryGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Publications
Record updated
27 March 2026